Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrante

Showing results (91-100 of 350) with videos related to

Pageof 35
Sort By:
Clinical Journal of Gastroenterology|February 27, 2022
Proctocolectomy and ileal pouch-anal anastomosis for the treatment of collagenous colitisGabriele Bislenghi, Marc Ferrante, Gert De Hertogh, et al.
European Journal of Gastroenterology & Hepatology|January 25, 2017
Effects of introduction of an inflammatory bowel disease nurse position on the quality of delivered careSofie Coenen, Ellen Weyts, Séverine Vermeire, et al.
International Journal of Pharmaceutics|October 16, 2022
The impact of inflammation on the expression of drug transporters and metabolic enzymes in colonic tissue from ulcerative colitis patientsTom de Waal, Niklas Handin, Joachim Brouwers, et al.
Digestive Diseases (Basel, Switzerland)|February 27, 2025
No Increased Risk of Venous Thromboembolism or Infectious Complications after Janus Kinase Inhibitor Exposure in Patients with Ulcerative Colitis Undergoing SurgeryIne De Greef, Gabriele Bislenghi, Isabelle Terrasson, et al.
Journal of Crohn'S & Colitis|July 13, 2016
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative ColitisKonstantinos Papamichael, Filip Baert, Sophie Tops, et al.
Inflammatory Bowel Diseases|February 24, 2021
Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel DiseaseSare Verstockt, Bram Verstockt, Kathleen Machiels, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2018
Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testingBram Verstockt, Gitte Moors, Sumin Bian, et al.
Gut|July 16, 2018
TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?Bram Verstockt, Sare Verstockt, Helene Blevi, et al.
European Journal of Gastroenterology & Hepatology|January 14, 2016
Identifying predictors of low adherence in patients with inflammatory bowel diseaseSofie Coenen, Ellen Weyts, Vera Ballet, et al.
Journal of Crohn'S & Colitis|October 20, 2019
The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis FactorMagali de Bruyn, Randy Ringold, Erik Martens, et al.
Pageof 35

Showing results (91-100 of 350) with videos related to

Sort By:
Pageof 35
Clinical Journal of Gastroenterology|February 27, 2022
Proctocolectomy and ileal pouch-anal anastomosis for the treatment of collagenous colitisGabriele Bislenghi, Marc Ferrante, Gert De Hertogh, et al.
European Journal of Gastroenterology & Hepatology|January 25, 2017
Effects of introduction of an inflammatory bowel disease nurse position on the quality of delivered careSofie Coenen, Ellen Weyts, Séverine Vermeire, et al.
International Journal of Pharmaceutics|October 16, 2022
The impact of inflammation on the expression of drug transporters and metabolic enzymes in colonic tissue from ulcerative colitis patientsTom de Waal, Niklas Handin, Joachim Brouwers, et al.
Digestive Diseases (Basel, Switzerland)|February 27, 2025
No Increased Risk of Venous Thromboembolism or Infectious Complications after Janus Kinase Inhibitor Exposure in Patients with Ulcerative Colitis Undergoing SurgeryIne De Greef, Gabriele Bislenghi, Isabelle Terrasson, et al.
Journal of Crohn'S & Colitis|July 13, 2016
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative ColitisKonstantinos Papamichael, Filip Baert, Sophie Tops, et al.
Inflammatory Bowel Diseases|February 24, 2021
Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel DiseaseSare Verstockt, Bram Verstockt, Kathleen Machiels, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2018
Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testingBram Verstockt, Gitte Moors, Sumin Bian, et al.
Gut|July 16, 2018
TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?Bram Verstockt, Sare Verstockt, Helene Blevi, et al.
European Journal of Gastroenterology & Hepatology|January 14, 2016
Identifying predictors of low adherence in patients with inflammatory bowel diseaseSofie Coenen, Ellen Weyts, Vera Ballet, et al.
Journal of Crohn'S & Colitis|October 20, 2019
The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis FactorMagali de Bruyn, Randy Ringold, Erik Martens, et al.
Pageof 35